Works matching AU Lotan, Yair

Results: 242
    1
    2
    3
    4

    Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1218, doi. 10.3390/jcm9041218
    By:
    • Yeh, Hsin-Chih;
    • Li, Ching-Chia;
    • Wen, Sheng-Chen;
    • Singla, Nirmish;
    • Woldu, Solomon L.;
    • Robyak, Haley;
    • Huang, Chun-Nung;
    • Ke, Hung-Lung;
    • Li, Wei-Ming;
    • Lee, Hsiang-Ying;
    • Li, Chia-Yang;
    • Yeh, Bi-Wen;
    • Yang, Sheau-Fang;
    • Tu, Hung-Pin;
    • Shariat, Shahrokh F.;
    • Sagalowsky, Arthur I.;
    • Raman, Jay D.;
    • Lotan, Yair;
    • Hsieh, Jer-Tsong;
    • Margulis, Vitaly
    Publication type:
    Article
    5
    6
    7
    8

    A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma.

    Published in:
    Science Translational Medicine, 2012, v. 4, n. 137, p. 1, doi. 10.1126/scitranslmed.3003643
    By:
    • Sivanand, Sharanya;
    • Peña-Llopis, Samuel;
    • Hong Zhao;
    • Kucejova, Blanka;
    • Spence, Patrick;
    • Pavia-Jimenez, Andrea;
    • Yamasaki, Toshinari;
    • McBride, David J.;
    • Gillen, Jessica;
    • Wolff, Nicholas C.;
    • Morlock, Lorraine;
    • Lotan, Yair;
    • Raj, Ganesh V.;
    • Sagalowsky, Arthur;
    • Margulis, Vitaly;
    • Cadeddu, Jeffrey A.;
    • Ross, Mark T.;
    • Bentley, David R.;
    • Kabbani, Wareef;
    • Xian-Jin Xie
    Publication type:
    Article
    9
    10
    11
    12
    13

    Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy.

    Published in:
    AUANews, 2023, p. 16
    By:
    • Kirk, Peter S.;
    • Lotan, Yair;
    • Zargar, Homayoun;
    • Fairey, Adrian S.;
    • Dinney, Colin P.;
    • Mir, Maria C.;
    • Krabbe, Laura-Maria;
    • Cookson, Michael S.;
    • Jacobson, Niels-Erik;
    • Montgomery, Jeffrey S.;
    • Vasdev, Nikhil;
    • Yu, Evan Y.;
    • Xylinas, Evanguelos;
    • Kassouf, Wassim;
    • Dall’Era, Marc A.;
    • Sridhar, Srikala S.;
    • McGrath, Jonathan S.;
    • Aning, Jonathan;
    • Shariat, Shahrokh F.;
    • Thorpe, Andrew C.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    Tumor Board: Bladder Cancer.

    Published in:
    AUANews, 2018, p. 17
    By:
    • Skinner, Eila;
    • Lotan, Yair;
    • Lerner, Seth;
    • Vapiwala, Neha;
    • Friedlander, Terence W.
    Publication type:
    Article
    20
    21

    Bladder Cancer.

    Published in:
    2016
    By:
    • Lotan, Yair;
    • Quek, Marcus L.;
    • Malkowicz, S. Bruce
    Publication type:
    Case Study
    22
    23
    24

    The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.

    Published in:
    International Journal of Surgical Pathology, 2023, v. 31, n. 2, p. 157, doi. 10.1177/10668969221095173
    By:
    • Mertens, Laura S.;
    • Claps, Francesco;
    • Mayr, Roman;
    • Hodgson, Anjelica;
    • Shariat, Shahrokh F.;
    • Hippe, Katrin;
    • Neuzillet, Yann;
    • Sanders, Joyce;
    • Burger, Maximilian;
    • Pouessel, Damien;
    • Otto, Wolfgang;
    • van der Kwast, Theo H.;
    • Lotan, Yair;
    • Allory, Yves;
    • Downes, Michelle R.;
    • van Rhijn, Bas W.G.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Erratum: BAP1 loss defines a new class of renal cell carcinoma.

    Published in:
    2012
    By:
    • Peña-Llopis, Samuel;
    • Vega-Rubín-de-Celis, Silvia;
    • Liao, Arnold;
    • Leng, Nan;
    • Pavía-Jiménez, Andrea;
    • Wang, Shanshan;
    • Yamasaki, Toshinari;
    • Zhrebker, Leah;
    • Sivanand, Sharanya;
    • Spence, Patrick;
    • Kinch, Lisa;
    • Hambuch, Tina;
    • Jain, Suneer;
    • Lotan, Yair;
    • Margulis, Vitaly;
    • Sagalowsky, Arthur I;
    • Summerour, Pia Banerji;
    • Kabbani, Wareef;
    • Wong, S W Wendy;
    • Grishin, Nick
    Publication type:
    Erratum
    31

    BAP1 loss defines a new class of renal cell carcinoma.

    Published in:
    Nature Genetics, 2012, v. 44, n. 7, p. 751, doi. 10.1038/ng.2323
    By:
    • Peña-Llopis, Samuel;
    • Vega-Rubín-de-Celis, Silvia;
    • Liao, Arnold;
    • Leng, Nan;
    • Pavía-Jiménez, Andrea;
    • Wang, Shanshan;
    • Yamasaki, Toshinari;
    • Zhrebker, Leah;
    • Sivanand, Sharanya;
    • Spence, Patrick;
    • Kinch, Lisa;
    • Hambuch, Tina;
    • Jain, Suneer;
    • Lotan, Yair;
    • Margulis, Vitaly;
    • Sagalowsky, Arthur I;
    • Summerour, Pia Banerji;
    • Kabbani, Wareef;
    • Wong, S W Wendy;
    • Grishin, Nick
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Prognostic impact of insulin‐like growth factor‐I and its binding proteins, insulin‐like growth factor‐I binding protein‐2 and ‐3, on adverse histopathological features and survival outcomes after radical cystectomy.

    Published in:
    International Journal of Urology, 2022, v. 29, n. 7, p. 676, doi. 10.1111/iju.14869
    By:
    • Sari Motlagh, Reza;
    • Schuettfort, Victor M;
    • Mori, Keiichiro;
    • Katayama, Satoshi;
    • Rajwa, Pawel;
    • Aydh, Abdulmajeed;
    • Grossmann, Nico C;
    • Laukhtina, Ekaterina;
    • Pradere, Benjamin;
    • Mostafai, Hadi;
    • Quhal, Fahad;
    • Abufaraj, Mohammad;
    • Lee, Richard;
    • Karakiewicz, Pierre I;
    • Lotan, Yair;
    • Comprate, Eva;
    • Moschini, Marco;
    • Gontero, Paolo;
    • Shariat, Shahrokh F
    Publication type:
    Article
    42
    43
    44

    A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy.

    Published in:
    BJU International, 2025, v. 135, n. 4, p. 648, doi. 10.1111/bju.16572
    By:
    • de Jong, Joep J.;
    • Proudfoot, James A.;
    • Daneshmand, Siamak;
    • Svatek, Robert S.;
    • Narayan, Vikram;
    • Gibb, Ewan A.;
    • Davicioni, Elai;
    • Joshi, Shreyas;
    • Dahmen, Aaron;
    • Li, Roger;
    • Inman, Brant A.;
    • Shah, Paras;
    • Chaplin, Iftach;
    • Wright, Jonathan;
    • Lotan, Yair
    Publication type:
    Article
    45

    The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer.

    Published in:
    BJU International, 2025, v. 135, n. 1, p. 88, doi. 10.1111/bju.16493
    By:
    • Liu, Kang;
    • Nicoletti, Rossella;
    • Zhao, Hongda;
    • Chen, Xuan;
    • Chiu, Peter Ka‐Fung;
    • Ng, Chi‐Fai;
    • Pichler, Renate;
    • Mertens, Laura S.;
    • Yanagisawa, Takafumi;
    • Afferi, Luca;
    • Mari, Andrea;
    • Katayama, Satoshi;
    • Rivas, Juan Gomez;
    • Campi, Riccardo;
    • Mir, Maria Carmen;
    • Rink, Michael;
    • Lotan, Yair;
    • Rouprêt, Morgan;
    • Shariat, Shahrokh F.;
    • Teoh, Jeremy Yuen‐Chun
    Publication type:
    Article
    46
    47
    48
    49
    50

    Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.

    Published in:
    BJU International, 2021, v. 128, n. 1, p. 79, doi. 10.1111/bju.15289
    By:
    • Soria, Francesco;
    • Black, Peter C.;
    • Fairey, Adrian S.;
    • Cookson, Michael S.;
    • Yu, Evan Y.;
    • Kassouf, Wassim;
    • Dall'Era, Marc A.;
    • Sridhar, Srikala S.;
    • McGrath, John S.;
    • Wright, Jonathan L.;
    • Thorpe, Andrew C.;
    • Morgan, Todd M.;
    • Daneshmand, Siamak;
    • Holzbeierlein, Jeff M.;
    • Bivalacqua, Trinity J.;
    • North, Scott;
    • Barocas, Daniel A.;
    • Lotan, Yair;
    • Grivas, Petros;
    • Stephenson, Andrew J.
    Publication type:
    Article